{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:51:07Z","timestamp":1780599067069,"version":"3.54.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1038\/s41581-021-00499-z","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T10:18:43Z","timestamp":1633947523000},"page":"788-789","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["COVID-19 vaccination in patients receiving dialysis"],"prefix":"10.1038","volume":"17","author":[{"given":"Benjamin","family":"Wilde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4898-0389","authenticated-orcid":false,"given":"Johannes","family":"Korth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4859-7507","authenticated-orcid":false,"given":"Andreas","family":"Kribben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"499_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab200","author":"E Goffin","year":"2021","unstructured":"Goffin, E. et al. COVID-19 related mortality in kidney transplant and hemodialysis patients: a comparative, prospective registry based study. Nephrol. Dial. Transplan. https:\/\/doi.org\/10.1093\/ndt\/gfab200 (2021).","journal-title":"Nephrol. Dial. Transplan."},{"key":"499_CR2","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"DS Khoury","year":"2021","unstructured":"Khoury, D. S. et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 27, 1205\u20131211 (2021).","journal-title":"Nat. Med."},{"key":"499_CR3","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.2215\/CJN.04080321","volume":"16","author":"L Chan","year":"2021","unstructured":"Chan, L., Fuca, N., Zeldis, E., Campbell, K. N. & Shaikh, A. Antibody response to mRNA-1273 SARS-CoV-2 vaccine in hemodialysis patients with and without prior COVID-19. Clin. J. Am. Soc. Nephrol. 16, 1258\u20131260 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"499_CR4","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/S0140-6736(21)01854-7","volume":"398","author":"EJ Carr","year":"2021","unstructured":"Carr, E. J. et al. Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients. Lancet 398, 1038\u20131041 (2021).","journal-title":"Lancet"},{"key":"499_CR5","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1126\/science.abj4176","volume":"373","author":"A Pegu","year":"2021","unstructured":"Pegu, A. et al. Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants. Science 373, 1372\u20131377 (2021).","journal-title":"Science"},{"key":"499_CR6","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.kint.2021.03.009","volume":"99","author":"CL Clarke","year":"2021","unstructured":"Clarke, C. L. et al. Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection. Kidney Int. 99, 1470\u20131477 (2021).","journal-title":"Kidney Int."},{"key":"499_CR7","doi-asserted-by":"publisher","DOI":"10.1101\/2021.08.16.21262115","author":"A Dulovic","year":"2021","unstructured":"Dulovic, A. et al. Diminishing immune responses against variants of concern in dialysis patients four months after SARS-CoV-2 mRNA vaccination. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2021.08.16.21262115 (2021).","journal-title":"medRxiv"},{"key":"499_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab152","author":"M Dekervel","year":"2021","unstructured":"Dekervel, M. et al. Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance hemodialysis. Clin. Kidney J. https:\/\/doi.org\/10.1093\/ckj\/sfab152 (2021).","journal-title":"Clin. Kidney J."},{"key":"499_CR9","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S0140-6736(21)01699-8","volume":"398","author":"A Flaxman","year":"2021","unstructured":"Flaxman, A. et al. Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). Lancet 398, 981\u2013990 (2021).","journal-title":"Lancet"},{"key":"499_CR10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109072","author":"M Bergwerk","year":"2021","unstructured":"Bergwerk, M. et al. Covid-19 breakthrough infections in vaccinated health care workers. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2109072 (2021).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00499-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00499-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00499-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T13:12:34Z","timestamp":1637068354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00499-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["499"],"URL":"https:\/\/doi.org\/10.1038\/s41581-021-00499-z","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]},"assertion":[{"value":"27 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.W. was funded by the Dr. Werner Jackst\u00e4dt Foundation and received travel reimbursements and\/or honoraria from Alexion, Chiesi, Hexal, Otsuka, TEVA, Sanofi and Wyeth. A.K. received travel reimbursements, honoria and\/or grants from Ablynx, Advitos, Alexion, Amgen, Astellas, AstraZeneca, Baxter, Bayer Vital, Bristol Myers Squibb, B. Braun Avitum, Binding Site, Charit\u00e9, Chiesi, Cyto Sorbents, Exthera Medical, GlaxoSmithKline, GE Healthcare, InflaRx, Jafron, Janssen-Cilag, Kyowa Kirin, Neovii Biotech, Novartis, Otsuka, Peripal, Pfizer, Reata Pharmaceuticals, Sanofi-Aventis, Shire-Takeda, Syneos Health and Vifor Fresenius. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}